Molecular tumor profiling has a significant impact on diagnosis and treatment of young patients with solid tumors
First results of the GAIN/iCAT2 Consortium trial show the importance of molecular profiling of solid tumors in young patients. Next generation sequencing (NGS) assays are now a standard part of clinical care for many adult solid...
Read More